Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00924_DB05039_nanopub.RA0EM7qjp8X-99hD82SNUWSQE72e-5jkYvYW856rnUHbg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00924_DB05039 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00924_DB05039 label "DDI between Cyclobenzaprine and Indacaterol - Concomitant therapy with monoamine oxidase inhibitors, tricyclic antidepressants, or other drugs that prolong the QTc interval should be monitored closely. These drugs may potentiate the effect of adrenergic agonist on the cardiovascular system. [drugbank_resource:DB00924_DB05039]" assertion.
- drugbank_resource:DB00924_DB05039 identifier "drugbank_resource:DB00924_DB05039" assertion.
- drugbank_resource:DB00924_DB05039 title "DDI between Cyclobenzaprine and Indacaterol - Concomitant therapy with monoamine oxidase inhibitors, tricyclic antidepressants, or other drugs that prolong the QTc interval should be monitored closely. These drugs may potentiate the effect of adrenergic agonist on the cardiovascular system." assertion.
- drugbank:DB05039 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00924_DB05039 assertion.
- drugbank:DB00924 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00924_DB05039 assertion.